Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENXP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,021
Award facts
- Contract value 100% obligated
- $17,021.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,021.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued without set-aside designation on December 15, 2025, represents a single award under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The delivery order is scheduled for completion by December 16, 2025, with performance to be executed at the contractor's Park Ridge facility.
DMS Pharmaceutical Group holds a single-award IDC valued at $499,999,999 through December 31, 2036, under the broader $30.3 billion PPV-G GEN V acquisition strategy, which establishes regional prime vendor contractors to supply pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. The contractor's portfolio encompasses branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals including oncology treatments, immunosuppressants, emergency medications, and routine pharmaceutical products. As a critical supplier within the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group has demonstrated consistent performance across multiple delivery orders issued by the Defense Logistics Agency, positioning the company as a key provider supporting military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DU26FENXP?
SPE2DU26FENXP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DU26FENXP worth?
The government has obligated $17,021 on SPE2DU26FENXP.
Is contract SPE2DU26FENXP an order under another contract?
Yes. SPE2DU26FENXP is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENXP competed?
The extent of competition for SPE2DU26FENXP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award